Published in Health Business Week, March 13th, 2009
"We are delighted with the addition of Dr. Gillis to our board," stated Harry Bushong, president of nanoTox. "He is well respected in both academia and the science community, and his leadership and experience will be invaluable as we work with nanoscience companies to ensure the safety of their products and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.